Non-digestible Carbohydrates Research Articles

Rethinking the classification of non-digestible carbohydrates: Perspectives from the gut microbiome.

Clarification is required when the term "carbohydrate" is used interchangeably with "saccharide" and "glycan." Carbohydrate classification based on human digestive enzyme activities brings clarity to the energy supply function of digestible sugars and starch. However, categorizing structurally diverse non-digestible carbohydrates (NDCs) to make dietary intake recommendations for health promotion remains elusive. In this review, we present a summary of the strengths and weaknesses of the traditional dichotomic classifications of carbohydrates, which were introduced by food chemists, nutritionists, and microbiologists. In parallel, we discuss the current consensus on commonly used terms for NDCs such as "dietary fiber," "prebiotics," and "fermentable glycans" and highlight their inherent differences from the perspectives of gut microbiome. Moreover, we provide a historical perspective on the development of novel concepts such as microbiota-accessible carbohydrates, microbiota-directed fiber, targeted prebiotics, and glycobiome. Crucially, these novel concepts proposed by multidisciplinary scholars help to distinguish the interactions between diverse NDCs and the gut microbiome. In summary, the term NDCs created based on the inability of human digestive enzymes fails to denote their interactions with gut microbiome. Considering that the gut microbiome possesses sophisticated enzyme systems to harvest diverse NDCs, the subclassification of NDCs should be realigned to their metabolism by various gut microbes, particularly health-promoting microbes. Such rigorous categorizations facilitate the development of microbiome-targeted therapeutic strategies by incorporating specific types of NDCs.

A review of current analytical methods for the determination of dietary fiber in food

Fiber benefits health and is an essential requirement in the body's daily diet. The definition of fiber has been evolving over the past 70 years. Initially, the definition of fiber focused only on plant cell walls (cellulose, hemicellulose, pectin, cutin, glycoprotein) and intracellular storage and secretion substances (gum, mucilage). More recently, the world has focused on resistant starch and oligosaccharides. The CODEX definition of dietary fiber includes all non-digestible carbohydrate polymers with a degree of polymerization of 3 or higher, provided that they benefit health. Fiber has many components, requiring the development of different methods to analyze components such as fructo-oligosaccharide, galacto-oligosaccharide, polydextrose, resistant maltodextrin, resistant starch, etc. A series of AOAC methods have been developed to explore different types of fiber, and these methods are still valid and widely used. For the analysis of total fiber content, the enzymemass method according to Prosky (AOAC 985.29) was considered the gold standard when it was first published. However, this method only determines a part of the fiber. When adding up the specific fiber components calculated from different methods, some types of fiber are double counting. Therefore, the method for determining total fiber is constantly updated and revised. The Enzymatic-Gravimetric-Liquid Chromatography method has been developed and can fully determine the components of dietary fiber; the newly published updated version is AOAC 2022.01.

46 Feeding the weaned pig gut and beyond with non-nutritional additives

Abstract Weaning imposes simultaneous stress, resulting in reduced growth performance, increased susceptibility to diseases, and increased morbidity and mortality in weaned pigs. Weaning stress can induce negative changes in the intestine, including damaged intestinal integrity, disturbed digestive and absorptive capacity, increased intestinal oxidative stress, and microbial dysbiosis. Improving intestinal development and health is critically important for enhancing disease resistance and overall health of weaned pigs. This, in turn, can increase their survival rate during this vulnerable stage and improve their productive performance in later stages. A healthy gut may include, but is not limited to, several important features: a healthy proliferation of intestinal epithelial cells, an integrated gut barrier function, a preferable or balanced gut microbiota, and well-developed intestinal mucosa immunity. Burgeoning evidence suggests that many non-nutritional additives can enhance overall intestinal health and beyond by targeting one or several functions of the gut. However, the exact protective mechanisms may vary and are still not completely understood. For example, direct-fed microbials may confer health benefits on the host by producing antimicrobial products, regulating gut microbial profile or immunity, and/or enhancing gut barrier function. Non-digestible carbohydrates and prebiotics exhibit striking impacts on reshaping the composition of gut microbiota in the host by boosting the production of health-promoting bacteria. Phytochemicals, a large variety of secondary plant metabolites, have been known for their broad and promising biological properties, including anti-microbial, antioxidant, and immune-modulating activities. Several short chain fatty acids derivatives aim to target the upper gastrointestinal tract, where the major nutrients are digested and absorbed, to promote intestinal health of pigs. Moreover, butyrate and valerate glycerides exhibit strong in vitro antimicrobial effects against enterotoxigenic Escherichia coli F18, one of the dominant pathogens causing post-weaning diarrhea globally. There are more candidates in the list that have been used in weaned pigs and shown promising results on growth and health promotion. Therefore, increasing our current understanding of non-nutritional additives and their influences on intestinal function during weaning will facilitate the development of more dietary strategies that increase stress resilience of weaned pigs.

Impact of GOS and 2’-FL on the production and structural composition of membrane-associated exopolysaccharides by B. adolescentis and B. infantis

Bifidobacteria, which are increasingly linked to health benefits to the host, produce structurally complex exopolysaccharides which are considered to be effector molecules responsible for health effects. It is currently not clear how the bacterial growth conditions, and especially the carbon source, affect the structural composition of the EPS. Here we present our investigations into the impact of the addition of 2′-fucosyllactose (2’-FL) and galactooligosaccharides (GOS), which are non-digestible carbohydrates added to infant formula, as the sole carbon source during the growth of B. adolescentis and B. infantis. Intriguingly, B. adolescentis produced EPS with larger molecular weights in the presence of GOS or a mixture of GOS/2’-FL. B. infantis showed increased growth levels in the presence of 2’-FL, and also produced an α-1,4-glucan polymer, whose amount was increased when grown on GOS. These findings highlight the species-specific effects of growth conditions on EPS structures.

Dietary therapy of murine primary biliary cholangitis induces hepatocellular steatosis: A cautionary tale.

There is increased interest in utilizing dietary interventions to alter the progression of autoimmune diseases. These efforts are driven by associations of gut microbiota/metabolites with levels of short-chain fatty acids (SCFAs). Propionate is a key SCFA that is commonly used as a food preservative and is endogenously generated by bacterial fermentation of non-digestible carbohydrates in the gut. A thesis has suggested that a diet rich in propionate and other SCFAs can successfully modulate autoimmunity. Herein, we investigated the effect of long-term administration of propionylated high-amylose resistant starches (HAMSP) on the course of murine primary biliary cholangitis. Groups of female ARE-Del mice were fed an HAMSP diet either before or after disease onset. A detailed immunobiological analysis was performed involving autoantibodies and rigorous T-cell phenotyping, including enumeration of T-cell subsets in the spleen, liver, intestinal intraepithelial lymphocytes and lamina propria by flow cytometry. Histopathological scores were used to assess the frequency and severity of liver inflammation and damage to hepatocytes and bile ducts. Our results demonstrate that a long-term propionate-yielding diet re-populated the T-cell pool with decreased naïve and central memory T-cell subsets and an increase in the effector memory T cells in mice. Similarly, long-term HAMSP intake reduced CD4+CD8+ double-positive T cells in intraepithelial lymphocytes and the intestinal lamina propria. Critically, HAMSP consumption led to moderate-to-severe hepatocellular steatosis in ARE-Del mice, independent of the stage of autoimmune cholangitis. Our data suggest that administration of HAMSP induces both regulatory and effector T cells. Furthermore, HAMSP administration resulted in hepatocellular steatosis. Given the interest in dietary modulation of autoimmunity and because propionate is widely used as a food preservative, these data have significant implications. This study also provides new insights into the immunological and pathological effects of chronic propionate exposure.

Prebiotics for Induction and Maintenance of Remission in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.

Prebiotics are nondigestible carbohydrates fermented by gut bacteria into metabolites that confer health benefits. However, evidence on their role for inflammatory bowel disease (IBD) is unclear. This study systematically evaluated the research on prebiotics for treatment of IBD. A search was performed in PubMed, Embase, Cochrane, and Web of Science. Eligible articles included randomized controlled trials or prospective observational studies that compared a prebiotic with a placebo or lower-dose control in patients with IBD. Meta-analyses were performed using random-effects models for the outcomes of clinical remission, clinical relapse, and adverse events. Seventeen studies were included. For induction of clinical remission in ulcerative colitis (UC), the fructooligosaccharide (FOS) kestose was effective (relative risk, 2.75, 95% confidence interval, 1.05-7.20; n = 40), but oligofructose-enriched inulin (OF-IN) and lactulose were not. For maintenance of remission in UC, germinated barley foodstuff trended toward preventing clinical relapse (relative risk, 0.40; 95% confidence interval, 0.15-1.03; n = 59), but OF-IN, oat bran, and Plantago ovata did not. For Crohn's disease, OF-IN and lactulose were no different than controls for induction of remission, and FOS was no different than controls for maintenance of remission. Flatulence and bloating were more common with OF-IN; reported adverse events were otherwise similar to controls for other prebiotics. Prebiotics, particularly FOS and germinated barley foodstuff, show potential as effective and safe dietary supplements for induction and maintenance of remission in UC, respectively. The overall certainty of evidence was very low. There would be benefit in further investigation on the role of prebiotics as treatment adjuncts for IBD.

Gut microbiota signatures of vulnerability to food addiction in mice and humans

ObjectiveFood addiction is a multifactorial disorder characterised by a loss of control over food intake that may promote obesity and alter gut microbiota composition. We have investigated the potential involvement...

Probing into the impacts of endogenous and exogenous short chain fatty acids (SCFAs) in fish health and growth

Abstract Short-chain fatty acids (SCFAs) are small organic acids exist in the fish gastrointestinal tract, mainly acetate, propionate, and butyrate. These SCFAs are produced through anaerobic fermentation of dietary non-digestible carbohydrates by gut microbes. Though enough studies have been devoted to showcasing the potential of SCFAs in human nutrition, the research on their production, potential, and existence in fish has been comparatively limited until recently. This review aims to provide a comprehensive overview of the current knowledge regarding SCFAs in aquaculture. It starts with commenting on the different sources, such as substrate and microbial species that are responsible for the production of SCFAs and their transportation and ends up depicting the relationship between biofloc technology and SCFAs production. This review also discusses the factors influencing SCFA production, such as environment, diet, and feeding habits of fish. Furthermore, the biological functions of SCFAs have been highlighted, and critical findings were compiled, including immunomodulatory effects, physiological response, gut health, and immunity.

85 The influence of supplementing isolated or intact structural fiber on the physicochemical properties of digesta and fecal consistency of nursery pigs

Abstract In human nutrition, functional fiber refers to isolated non-digestible carbohydrates with physiological roles, while structural fiber pertains to those that are intrinsic and intact in plants. Increasing dietary fiber in post-weaning pig diets has been shown to improve gastrointestinal health and alter fecal consistency. However, minimal research has been conducted on the role of supplementing isolated functional or structural fiber that are chemically insoluble in nursery diets. The experimental objective was to evaluate the effect of functional or structural insoluble fiber supplementation on the physicochemical properties of digesta and feces during the nursery period. A total of 256 newly weaned pigs were randomly assigned to one of four treatments across two replications with 4 pigs per pen and 16 pens per treatment for a 35-d study. The average initial pig body weight (BW) was 5.13 ± 0.65 kg and same sex pens were used and balanced across treatments. Dietary treatments consisted of a control nursery diet (PC), PC with 3% soy hulls (NC), PC with 2% isolated lignocellulose (ISO), and PC with 2% structural lignocellulose (STR). Treatments were fed across phase 1 (d 0-7) and phase 2 (d 7-21) diets, and a common diet was fed in phase 3 (d 21-35). On d 7, 14, 21, 28, and 35, fresh fecal samples were collected to determine water binding capacity (WBC), water swelling capacity (WSC), and fecal dry matter (DM). Fecal scores were also evaluated using a predefined scale (1 = solid; 4 = liquid). On d 21, one pig per pen closest to the mean BW was necropsied, and ileal, cecal, and colonic digesta were collected. Continuous data were analyzed as a linear mixed model (PROC MIXED) with treatment, sex, and period as fixed effects, replicate as a random effect, and initial BW as a covariate where appropriate. Fecal scores were analyzed using a multinomial model in PROC GENMOD and FREQ. Pigs fed ISO and STR tended to have greater fecal DM (24.1%, 24.6%, 25.4%, and 26.29% for PC, NC, ISO, and STR, respectively; P = 0.071). There was a greater proportion of solid and semi-solid feces in pigs fed ISO (P = 0.039). Fecal WBC was greatest in pigs fed PC, with NC and ISO performing intermediately, and STR having the least (2.66, 2.55, 2.50, and 2.39 mL/g of DM for PC, NC, ISO, and STR, respectively; P = 0.071). Fecal WSC increased with time (P < 0.001), but there was no impact of treatment (P = 0.983). Ileal digesta pH was decreased in NC and STR, relative to PC and ISO, (P = 0.007). There tended to be a similar response for cecal pH (P = 0.092). Pigs fed PC tended to have the greatest colonic WBC (P = 0.058). Collectively, supplementing isolated or structural lignocellulose can alter the physicochemical properties of nursery pig feces.

Development of the CE-C4D method for determination of organic acids in infants faeces using an in-house built instrument

Short-chain fatty acids (SCFAs) are a major group of products produced during colonic bacterial fermentation of nondigestible carbohydrates demonstrating several important functions, e.g. regulating the immune system activity or the lipid metabolism. A detailed profile and concentration characterization of SCFAs in infant faeces is essential for expanding knowledge regarding the role of SCFAs in infant physiology and pathophysiology. This research presents the development and validation of a capillary electrophoresis method with a contactless capacitively coupled conductivity detector (CE-C4D) for the analysis of SCFAs and succinic and lactic acids in infant faeces. The study focused on optimizing the background electrolyte, mainly dynamic capillary coating with polybrene, and utilizing cyclodextrins to achieve efficient separation. Validation parameters, such as linearity (0.993 – 0.998), limits of detection and quantification (LOD: 0.10 – 0.89 μg/mL; LOQ: 0.35 – 2.97 μg/mL), intra- and inter-day precision (1.71 – 5.69 % and 1.11 – 12.5 %, respectively), injection repeatability (0.91 – 5.70 %), trueness (-12.8 – 3.80 %), and matrix effect (78.8 – 108.6 %), were assessed and the method was found suitable for the purpose. The demonstrated method was successfully applied to determine nine organic acids in faecal samples.

Effect of Short-Chain Fatty Acids on Inflammatory and Metabolic Function in an Obese Skeletal Muscle Cell Culture Model.

The fermentation of non-digestible carbohydrates produces short-chain fatty acids (SCFAs), which have been shown to impact both skeletal muscle metabolic and inflammatory function; however, their effects within the obese skeletal muscle microenvironment are unknown. In this study, we developed a skeletal muscle in vitro model to mimic the critical features of the obese skeletal muscle microenvironment using L6 myotubes co-treated with 10 ng/mL lipopolysaccharide (LPS) and 500 µM palmitic acid (PA) for 24 h ± individual SCFAs, namely acetate, propionate and butyrate at 0.5 mM and 2.5 mM. At the lower SCFA concentration (0.5 mM), all three SCFA reduced the secreted protein level of RANTES, and only butyrate reduced IL-6 protein secretion and the intracellular protein levels of activated (i.e., ratio of phosphorylated-total) NFκB p65 and STAT3 (p < 0.05). Conversely, at the higher SCFA concentration (2.5 mM), individual SCFAs exerted different effects on inflammatory mediator secretion. Specifically, butyrate reduced IL-6, MCP-1 and RANTES secretion, propionate reduced IL-6 and RANTES, and acetate only reduced RANTES secretion (p < 0.05). All three SCFAs reduced intracellular protein levels of activated NFκB p65 and STAT3 (p < 0.05). Importantly, only the 2.5 mM SCFA concentration resulted in all three SCFAs increasing insulin-stimulated glucose uptake compared to control L6 myotube cultures (p < 0.05). Therefore, SCFAs exert differential effects on inflammatory mediator secretion in a cell culture model, recapitulating the obese skeletal muscle microenvironment; however, all three SCFAs exerted a beneficial metabolic effect only at a higher concentration via increasing insulin-stimulated glucose uptake, collectively exerting differing degrees of a beneficial effect on obesity-associated skeletal muscle dysfunction.

Clinical Uses of Fructooligosaccharides for Gastrointestinal health in the Pediatric Population

Fructooligosaccharides (FOS) are non-digestible carbohydrates that are one of the major classes of bifidogenic oligosaccharides. Studies find that prebiotics such as FOS display health benefits pertaining to but not restricted to the gastrointestinal tract of an infant. This review article aims to discuss the therapeutic potential of FOS for different pediatric gut conditions. FOS in varying concentration has been found to prevent constipation and soften stools; reduce the incidence and severity of diarrhoea; alleviate GI discomfort symptoms such as vomiting and regurgitation. Infants and children seem to tolerate both short and long chain FOS molecules well. Although FOS is beneficial for infant and child health, there is still a need for rigorous clinical trials and long term follow up studies to understand if FOS supplemented in infancy can confer long term effects in adulthood.

Alkali treatment of maize bran affects utilization of arabinoxylan and other non-digestible carbohydrates by the human gut microbiota in vitro in a dose-dependent manner

Alkali treatment of maize bran can break ferulate cross-linking and increase utilization of alkali-solubilized arabinoxylan (AX) by the human gut microbiome. However, it is not known how alkali treatment affects the utilization of AX and other non-digestible carbohydrates (NDC) that remain insoluble after alkali treatment, or how varying degrees of alkali treatment affect NDC fermentation. Therefore, maize bran was treated with alkali ranging from 0 to 1.25 M NaOH, neutralized, and then subjected to in vitro digestion and fermentation using human fecal microbiomes. Increasing alkali concentration progressively increased water solubility of NDC, especially AX, and increased microbial fermentation of water-soluble AX (p < 0.001) during fermentation; however, there was a decrease in fermentation of insoluble AX and NDC (p < 0.001). Across microbiomes, more acetate (p = 0.004) and propionate (p = 0.018), but less butyrate (p < 0.001), were produced as alkali treatment of maize bran increased. Higher alkali treatments increased the abundances of Bifidobacterium (q < 0.001), Bacteroides (q = 0.0015), Faecalibacterium (q < 0.001), and several genera in the Bacilli class (q < 0.001), while decreasing Bilophila (q < 0.001), Butyricicoccus (q < 0.001), and several Lachnospiraceae (q < 0.001). Soluble but not insoluble NDC utilization was improved by extracting residual free phenolic compounds from alkali-treated maize bran (p = 0.005 and p = 0.39, respectively). In conclusion, alkali makes maize bran AX more water soluble and fermentable, but it has a negative impact on insoluble AX and NDC utilization, which reduces butyrate production by the microbiome due to decreases in Butyricicoccus and some Lachnospiraceae.

Effect of prebiotics, probiotics, and synbiotics on gut microbiome in diabetes among coastal communities

Cutting-edge research on oceans and human health is enhancing our comprehension of disease-causing organisms in coastal ecosystems. Coastal areas are affected by pollution resulting from the changes in hydrology and land utilization. In the coastal population, an elevated incidence of diabetes was observed. Diabetes mellitus is a prominent metabolic disease that is causing major burdens for patients as well as physicians. Diabetes is an intricate condition that encompasses several molecular pathways associated with the gut microbiome. The gut microbiome significantly influences the permeability of the gastrointestinal mucosa. Alterations in the wide range of gut microbiomes have been associated with various health issues including diabetes. The two major contributors to type 2 diabetes are insulin resistance and inflammation which may result in metabolic dysregulation due to dysbiosis. Due to gut dysbiosis, diabetes may show high prevalence in individuals living in coastal areas. The correlation between dysbiosis and diabetes can be made, especially considering probiotics have been demonstrated to have some impact in helping diabetic patients with their interrupted metabolism revert to normal. Probiotic intake has reportedly resulted in improved metabolic control among patients with type 2 diabetes. Prebiotics can be non-digestible carbohydrates that are naturally extracted or synthetically produced. Uses of synbiotics show a synergistic impact on type 2 diabetes by altering the gut environment. In coastal communities, the potential effects of probiotic, prebiotic, and synbiotic therapy on the gut microbiome of diabetic patients have been investigated. Although these therapies have demonstrated encouraging results in coastal areas, more research is needed to fully understand their implications for controlling diabetes in this setting. In this review, we describe the role of the gut microbiome in diabetes patients residing in coastal regions and the underlying mechanisms that existed for analysing and predicting the function of the microbiome in diabetic people. The role of pre, pro, and synbiotics in type 1 and type 2 diabetes are precisely summarized. Keywords: Type 1 diabetes, gut microbiome, type 2 diabetes, coastal region, dysbiosis, prebiotics, synbiotics, probiotics.

Physiologic Effects of Isolated or Synthetic Dietary Fiber in Children: A Scoping Review

BackgroundFiber is an integral part of a healthy diet. Studies have shown that the fiber intake in children is below adequate amounts, leading to adverse health outcomes. ObjectivesThis study aimed to perform a scoping review to assess the available evidence for the impact of isolated and synthetic dietary fiber on children’s health outcomes. MethodsA systematic literature search was conducted in Ovid Medline, Ovid Global Health, Embase, and Cochrane Library via Wiley to identify randomized controlled trials (RCTs) in healthy children aged 1–18 y at baseline who consumed added, isolated, or synthetic dietary fiber. The outcomes of interest were categorized based on the Food and Drug Administration’s guidance for industry on nondigestible carbohydrates and the Vahouny Fiber Symposium criteria, which included reduced fasting blood, glucose, total and/or LDL cholesterol concentrations, attenuation of postprandial glycemia/insulinemia, increased fecal bulk/laxation, reduced transit time, weight loss/reduction in adiposity, reduced energy intake from food consumption, increased satiety, bone health/enhanced mineral absorption, and blood pressure. We also cataloged additional reported outcomes. ResultsOf 3837 randomized controlled parallel or crossover trials screened at the abstract level, 160 were eligible for full-text review, and 32 included for data extraction. This scoping review presents analysis of data from 32 RCTs in children who were healthy, overweight/obese or had mild hypercholesterolemia. Inulin-type fructans (41%) and psyllium (22%) were the most frequently administered fiber types, with weight/adiposity, markers of lipid metabolism (41%), and bone-related markers (38%) being the most frequently reported health outcomes. Only a few RCTs have investigated the effects of laxation (9%), and none specifically studied the impact of fiber on reducing postprandial glycemia/insulinemia. ConclusionsThis scoping review demonstrates sufficient evidence for conducting systematic reviews and meta-analyses for several outcomes. Evidence gaps remain on the impact of isolated fibers on outcomes such as laxation, colonic transit time, and postprandial glycemia/insulinemia in children.

A novel “microbiota-host interaction model” to study the real-time effects of fermentation of non-digestible carbohydrate (NDCs) on gut barrier function

In this study, an in vitro co-culture model using an electric cell-substrate impedance sensing system (ECIS) for testing the impact of real-time fermentation of non-digestible carbohydrates (NDCs) by the intestinal microbiota on gut barrier function was established. We applied Lactobacillus plantarum WCFS1 as a model intestinal bacterium and alginate-pectin as immobilization polymers as well as a source of NDCs to determine the impact of pectin fermentation on the barrier function of T84 gut epithelial cells. In the first design, L. plantarum WCFS1 was encapsulated in an alginate capsule followed by embedding in an agar layer to mimic a firm mucus layer that might be present in the colon. In this experimental design, the presence of the agar layer interfered with the transepithelial electrical resistance (TEER) measurement of T84 cells. Subsequently, we removed the agar layer and used encapsulated bacteria in an alginate gel and found that the TEER measurement was adequate. The encapsulation of the L. plantarum WCFS1 does avoid direct contact with cells. Also, the encapsulation system allows higher amounts of packing densities of L. plantarum WCFS1 in a limited space which can limit the oxygen concentration within the capsule and therefore create anaerobic conditions. To test this design, T84 cells were co-incubated with L. plantarum alginate-capsules supplemented with graded loads of fermentable pectin (0, 4, and 8 mg/ml per capsule) to investigate the effect of pectin fermentation on gut barrier function. We observed that as the pectin content in the L. plantarum capsules increased, pectin showed a gradually stronger protective effect on the TEER of the gut epithelium. This could partly be explained by enhanced SCFA production as both lactate and acetate were enhanced in L. plantarum containing alginate capsules with 8 mg/ml pectin. Overall, this newly designed in vitro co-culture model allows for studying the impact of bacteria-derived fermentation products but also for studying the direct effects of NDCs on gut barrier function in a relatively high-throughput way.

Microencapsulation and controlled release of Bacillus clausii through a novel non-digestible carbohydrate formulation as revolutionizing probiotic delivery

Probiotics have gained significant attention in recent years due to the growing awareness of physical health and well-being. However, maintaining high concentrations of probiotics throughout the product's shelf life and during the gastrointestinal tract is crucial for ensuring their health-promoting effects. After determining an optimal formulation through a fractional factorial model, this study optimizes probiotic Bacillus Clausii delivery through spray-drying microencapsulation using a novel maltodextrin-alginate-inulin (MDX-ALG-IN) formulation (optimized ratio: 7:2:1). Notably, this formulation exclusively comprises non-digestible carbohydrates, marking a novel approach in probiotic encapsulation. Achieving a high Product Yield (51.06 %) and Encapsulation Efficiency (80.53 %), the study employed SEM for morphological analysis, revealing an irregular form and extensive surface in dentations characteristic of maltodextrin involvement. With a low moisture content of 3.02 % (±0.23 %) and 90.52 % solubility, the powder displayed exceptional properties. Probiotic viability remained robust, surviving up to 60 % even after 180 days at 4 °C, 25 °C, and 37 °C. Thermal characterization unveiled microcapsule resilience, exhibiting a glass transition temperature (Tg) at 138.61 °C and a melting point of 177.28 °C. The study systematically addresses crucial aspects of microencapsulation, including formulation optimization, morphological characteristics, and powder properties. Notably, the MDX-ALG-IN microcapsules demonstrated stability in simulated gastrointestinal conditions, indicating potential application for supplements and complex food matrices. In summary, this research contributes to microencapsulation understanding, emphasizing the MDX-ALG-IN formulation's efficacy in preserving probiotic viability across production stages and simulated digestive processes.

Taste of common prebiotic oligosaccharides: impact of molecular structure.

Prebiotic oligosaccharides are naturally occurring nondigestible carbohydrates with demonstrated health benefits. They are also a chemically diverse class of nutrients, offering an opportunity to investigate the impact of molecular structure on oligosaccharide taste perception. Accordingly, a relevant question is whether these compounds are detected by the human gustatory system, and if so, whether they elicit sweet or "starchy" taste. Here, in 3 psychophysical experiments, we investigated the taste perception of 3 commercially popular prebiotics [fructooligosaccharides (FOS), galactooligosaccharides (GOS), xylooligosaccharides (XOS)] in highly pure form. Each of these classes of prebiotics differs in the type of glycosyl residue, and position and type of bond between those residues. In experiments I and II, participants were asked to discriminate a total of 9 stimuli [FOS, GOS, XOS; degree of polymerization (DP) of 2, 3, 4] prepared at 75mM in the presence and absence of lactisole, a sweet receptor antagonist. We found that all 9 compounds were detectable (P < 0.05). We also found that GOS and XOS DP 4 were discriminable even with lactisole, suggesting that their detection was not via the canonical sweet receptor. Accordingly, in experiment III, the taste of GOS and XOS DP 4 were directly compared with that of MOS (maltooligosaccharides) DP 4-6, which has been reported to elicit "starchy" taste. We found that GOS and MOS were perceived similarly although narrowly discriminable, while XOS was easily discriminable from both GOS and MOS. The current findings suggest that the molecular structure of oligosaccharides impacts their taste perception in humans.

Gut Microbiome and Digestive Health

The human body is a complex ecosystem teeming with billions of bacteria known collectively as the gut microbiome. This diverse community of bacteria, viruses, fungi, and other microbes has emerged as an important player in the symphony of our overall health, with a focus on digestive health. The gut, a bustling metropolis where digestion, nutrition absorption, and immune control take place, lies at the heart of this microbial marvel. The gut microbiota, like a little symphony, meticulously choreographs many physiological processes. As our understanding grows, it becomes clear that the health of this microbial community is intrinsically linked to the health of the host. &#x0D; Digestive health, a cornerstone of our well-being, is dependent on the delicate balance of gut flora [1]. According to research, these bacteria and the host have a symbiotic relationship in which both sides benefit. Beneficial bacteria thrive in a healthy gut, aiding in the digestion of complex carbohydrates and the production of essential vitamins. This microbial community contributes to the fortification of the gut lining, which serves as a strong barrier against invading pathogens. Dybiosis, or an imbalance in the gut microbiota, on the other hand, may set the stage for a symphony of digestive problems. Changes in the delicate balance of the gut microbiota have been linked to conditions such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and gastroenteritis. Dybiosis has ramifications that go beyond the digestive tract, into the realms of systemic inflammation and immunological dysfunction [2]. &#x0D; Accepting the therapeutic potential of the gut microbiota is usually the first step toward digestive well-being. Probiotics, which are live microorganisms with proven health benefits, have emerged as champions in restoring intestinal balance. Beneficial bacteria, which may be found in fermented foods and supplements, function as reinforcements for the indigenous microbial armies, promoting a diverse and strong gut ecosystem. Furthermore, prebiotics, which are nondigestible carbohydrates that serve as fuel for beneficial bacteria, play an important role in maintaining a healthy gut microbiota. A diet high in plant-based fibers not only promotes digestive health but also serves as a foundation for beneficial microorganisms to thrive. &#x0D; The pursuit of intestinal harmony extends beyond orthodox therapy, with holistic treatments emphasizing the interdependence of lifestyle factors. Stress management, regular exercise, and a nutritious diet have all been identified as important in maintaining a healthy gut flora. The delicate dance between the mind and the gut, known colloquially as the "gut-brain axis," demonstrates the significant impact of psychological well-being on digestive health. As we enter the era of personalized medicine, advances in microbiome research pave the way for tailored therapeutics. Precision medicine in digestive health holds the possibility of discovering the unique fingerprint of an individual's gut microbiota and developing tailored strategies for improvement. This novel technology holds the prospect of more effective and personalized treatments for digestive illnesses. &#x0D; The gut microbiome is a witness to the complex interplay of the microscopic and macroscopic within the human body. Its influence on digestive health extends beyond the stomach, into the greater landscape of our overall well-being. Embracing this microbial ally via probiotics, prebiotics, and lifestyle changes heralds a new era in digestive health—one in which internal harmony becomes the foundation of our energy. The potential for transformative advances in digestive health as we solve the secrets of the gut microbiome draws us toward a future where microbial harmony is a guiding principle in the pursuit of wellness.

Evaluation of Olive Leaf Phenolic Compounds' Gastrointestinal Stability Based on Co-Administration and Microencapsulation with Non-Digestible Carbohydrates.

The large generation of olive by-products has motivated their revalorization into high-added-value products. In this regard, olive leaves pose as an interesting source of bioactive compounds, due to their phenolic content with commonly known antioxidant, anti-inflammatory, and immunomodulatory properties, with potential application in non-communicable diseases. However, their effectiveness and applicability into functional foods is limited by their instability under gastrointestinal conditions. Thus, the development of protective formulations is essential. In this study, the spray-drying encapsulation of a phenolic-rich olive leaf extract with inulin as the encapsulating agent was optimized. Then, the behavior of the free extract under gastrointestinal conditions, its co-administration with the encapsulating agent, and the optimized microencapsulated formulation were studied through an in vitro gastrointestinal digestion process following the INFOGEST protocol. Digestion of the free extract resulted in the degradation of most compounds, whereas this was minimized in the co-administration of the non-encapsulated extract with the encapsulating agent. This protective effect, related to its interaction with inulin, was similar to the microencapsulated formulation. Thus, both approaches, co-administration and microencapsulation with inulin, could be promising strategies for the improvement of the stability of these anti-inflammatory and immunomodulatory compounds under gastrointestinal conditions, enhancing their beneficial effect.